Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Medical Ultrasound (Electronic Edition) ›› 2022, Vol. 19 ›› Issue (11): 1238-1243. doi: 10.3877/cma.j.issn.1672-6448.2022.11.014

• Genitourinary Ultrasound • Previous Articles     Next Articles

Comparative study of enhanced ultrasound and contrast-enhanced helical CT in diagnosis of renal masses

Xiangru Dong1, Yinzhu Chu1, Fuxin Li1, Feng Zhang1, Yuying Zhang1, Changjun Wu1,()   

  1. 1. Department of Ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin 150000, China
  • Received:2021-03-22 Online:2022-11-01 Published:2023-01-19
  • Contact: Changjun Wu

Abstract:

Objective

To evaluate the value of contrast-enhanced helical computed tomography (CECT) and enhanced ultrasound (CEUS) in differentiating benign and malignant renal masses.

Methods

We retrospectively analyzed 48 patients with renal masses diagnosed by pathology at the First Affiliated Hospital of Harbin Medical University from September 2020 to March 2021, all of whom underwent CEUS and CECT examinations, and CEUS with Sonazoid. These patients were divided into either a benign group (n=10) or a malignant group (n=38) according to the pathological results. The diagnostic efficacy of the two imaging methods and the difference in the detection rates of malignant enhancement signs between them were compared by χ2 test. The mean enhancement duration of Sonazoid-CEUS in normal renal parenchyma was statistically calculated.

Results

Hyper-enhancement, inhomogeneous enhancement, fast fill in, and fast wash out showed higher diagnostic value in renal malignant tumors. The positive rate of "hyper-enhancement" in CEUS was obviously higher than that in CECT (92.11% vs 73.68%, χ2=4.547, P=0.33). CEUS had high application value in the diagnosis of benign and malignant renal tumors. The accuracy and specificity of CEUS were higher than those of CECT (95.83% vs 93.75%; 90.00% vs 80.00%), and its sensitivity was the same as that of CECT (97.37% vs 97.37%), the differences were not statistically significant (P>0.05). The mean duration of Sonazoid-CEUS enhancement in normal renal parenchyma was (6.43±1.20) min, with 34 patients (70.83%, 34/48) exceeding 7 min.

Conclusion

CEUS with Sonazoid prolongs the enhancement time of renal tumors and renal parenchyma. It has similar diagnostic efficacy to CECT in the assessment of benign and malignant renal tumors.

Key words: Renal masses, Sonazoid, Contrast-enhanced ultrasound, Diagnosis

Copyright © Chinese Journal of Medical Ultrasound (Electronic Edition), All Rights Reserved.
Tel: 010-51322630、2632、2628 Fax: 010-51322630 E-mail: csbjb@cma.org.cn
Powered by Beijing Magtech Co. Ltd